Fierce Pharma February 20, 2024
Nick Paul Taylor

Senators are urging the FDA to address the “alarming proliferation of dangerous and misleading content promoting prescription drugs.” The lawmakers cited changes to social media, the rise of influencers and promotion by telehealth companies as evidence that the agency needs to act.

Richard Durbin, D-Illinois, and Mike Braun, R-Indiana, wrote (PDF) to FDA Commissioner Robert Califf, M.D., after seeing several signs that the agency needs to “take swift action to update its enforcement tools to reflect the current platforms and methods used to promote prescription drugs and biologics, and to prioritize the protection of children from harmful and inaccurate medical advice.”

The senators claim advertisers are exploiting the holes in FDA’s oversight on social media at the expense of children...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, Pharma, Pharma / Biotech
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
Will Trump's healthcare appointments bring 'radical changes'?

Share This Article